Let’s Connect: Centricity Research will be in attendance at ATTD in Madrid, Spain & SCOPE in Orlando, Florida! Will we see you there?
Centricity Research will be in attendance at ATTD & SCOPE, engaging with…
Xeris scores first FDA nod with shelf-stable glucagon injector, syringe | FiercePharma
Exciting news for our sponsor Xeris Pharmaceutical: FDA has approved Xeris’s…
Centricity Research will be at #ADA2019 June 7-11 in San Francisco, CA!
Visit booth #2105 & chat with @karrivenn, President, about diabetes…
RESEARCH SPOTLIGHT: Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia
Centricity Research’s Chief Medical officer Dr. Ronnie Aronson shares…
LMC Presents: Bingo & Blood Sugars
On Saturday August 11th, LMC Healthcare hosted our first ever Bingo &…
Research & Innovation in Type 1 Diabetes: Dr. Ronnie Aronson Weighs in at ADA’s 78th Scientific Sessions
Over the past week, LMC Healthcare & Centricity Research have been in…
Centricity Research at 78th annual ADA - Booth #1226
Greetings! In anticipation of the upcoming 78th annual ADA, we would like to…
78th Scientific Sessions: LMC’s Dr. Ronnie Aronson to be highlighted at ADA’s Press Program/Official News Briefing for T1D Device Study!
LMC Healthcare & Centricity Research will be in attendance at the 2018…
LMC|Manna Research will be at the 2018 Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida – Will I be seeing you there?
LMC|Manna Research will be at the 2018 Summit for Clinical Ops Executives…
Dr Aronson's Paper Published in TouchEndocrinology.com's 2015 Summer Issue
Dr. Ronnie Aronson’s paper “The Functionally Refractory Patient in…